Article
Complementary Dual Approach for In Silico Target Identification of Potential Pharmaceutical Compounds in Cystic Fibrosis.
International journal of molecular sciences - 15 Oct 2022
Vinhoven Liza, Stanke Frauke, Hafkemeyer Sylvia, Nietert Manuel Manfred
Abstract excerpt
Cystic fibrosis is a genetic disease caused by mutation of the CFTR gene, which encodes a chloride and bicarbonate transporter in epithelial cells. Due to the vast range of geno- and phenotypes, it is difficult to find causative treatments; however, small-molecule therapeutics have been clinically approved in the last decade. Still, the search for novel therapeutics is ongoing, and thousands of compounds are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
